Peace of mind for patients with differentiated thyroid cancer?
Authors:
- 1 January 2013
- journal article
- Published by Georg Thieme Verlag KG in Nuklearmedizin-Nuclear Medicine
- Vol. 52 (04) , 115-120
Abstract
Differentiated thyroid carcinomas (DTC) have an excellent prognosis, with 10-year overall survival rates over 90%. In addition, DTC patients benefit from their lifelong medical surveillance. The aim of the study was to compare the patients’ overall survival with that of a matched general population. Patients and methods: We have analyzed 1497 consecutive patients with DTC, who underwent radioiodine therapy in Münster, Germany, according to international standards. We classified our patients according to the current 7th edition of the UICC (Union Internationale Contre le Cancer) classification and we compared the overall survival of the patients with the expected survival based on age and sex of the general population as provided by the Federal Statistical Office, Germany. Results: There were no significant differences in overall survival rates between DTC patients of the cohort in stages I to IVa compared to the expected survival based on age and sex of the general population. However, patients in stage IVc showed a significantly worse overall survival rate using the log-rank test (p < 0.0001). Conclusion: Patients with DTC showed excellent overall survival rates in stages I, II, III and IVa. All patients, except for those in stage IVc (M1 ≥ 45 years), had overall survival rates similar to the general population.Keywords
This publication has 25 references indexed in Scilit:
- Radioiodine remnant ablation in differentiated thyroid cancer after combined endogenous and exogenous TSH stimulationNuklearmedizin-Nuclear Medicine, 2012
- Radioiodine for remnant ablation and therapy of metastatic diseaseNature Reviews Endocrinology, 2011
- Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2009
- Primary tumour diameter as a risk factor for advanced disease features of differentiated thyroid carcinomaClinical Endocrinology, 2009
- Poorly Differentiated Thyroid Carcinoma: The Turin Proposal for the Use of Uniform Diagnostic Criteria and an Algorithmic Diagnostic ApproachAmerican Journal of Surgical Pathology, 2007
- Life expectancy in differentiated thyroid cancer: a novel approach to survival analysisEndocrine-Related Cancer, 2005
- Papillary and Follicular Thyroid CarcinomaNew England Journal of Medicine, 1998
- Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancerThe American Journal of Medicine, 1994
- Rank Tests and a One-Sample Logrank Test for Comparing Observed Survival Data to a Standard Population1981
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958